Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Potential new Alzheimer's drugs advancing in clinical trials

08.04.2010
After years of preparation and anticipation, scientists who discover and develop new medications are about to answer a key question about Alzheimer's disease: Will drugs that block formation of abnormal clumps of protein in the brain called amyloid-beta slow the progression of the devastating disease?

The cover story in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine, assesses the scientific foundation and clinical landscape of those amyloid-beta blockers.

C&EN Senior Editor Lisa Jarvis notes that amyloid-beta is at the heart of a central hypothesis — and simmering controversy — about Alzheimer's disease. Some scientists are convinced that amyloid-beta is the root cause of the nerve-cell death and subsequent mental decline in individuals with Alzheimer's disease.

Others think that something else, perhaps a still-unidentified environmental neurotoxin, is the real culprit. That mystery agent, they suspect, triggers formation of beta-amyloid.

If the clinical trials are successful, doctors within 5-10 years could have an arsenal of new drugs that can slow the progression of Alzheimer's. If the trials fail, its back to the drawing board to find new hypothesis and drug targets for the disease, the article notes.

Michael Bernstein | EurekAlert!
Further information:
http://www.acs.org

More articles from Life Sciences:

nachricht Biology meets geometry
31.10.2014 | University of California - Santa Barbara

nachricht Blocking a Fork in the Road to DNA Replication
31.10.2014 | Whitehead Institute for Biomedical Research

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Einladung zum Industriearbeitskreis

31.10.2014 | Veranstaltungen

Sehen ohne Brille: Modernste Laser-Verfahren und Kunstlinsen

31.10.2014 | Veranstaltungen

8. Deutscher Schulverpflegungskongress am 14. November in Vechta

31.10.2014 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Move!-Kopfstütze für Menschen mit Muskelschwäche gewinnt zweiten Platz beim Kölner Design Preis

31.10.2014 | Förderungen Preise

IBT® Connect von time4you verschafft Flexibilität bei der Integration von Lerninhalten

31.10.2014 | Unternehmensmeldung

Siemens erhält Aufträge über zwei neue Windprojekte in Kanada

31.10.2014 | Unternehmensmeldung